Earnest Partners LLC filed Amendment No. 13 to its Schedule 13G with the SEC on November 12, 2026, disclosing a 5.7% beneficial ownership position in Core Laboratories Inc. /DE/ as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: Earnest Partners LLC reported beneficial ownership of 2,629,631 shares of Core Laboratories Inc. common stock.
  • Percent of class: The 2,629,631 shares represent 5.7% of the class, according to the filing.
  • Sole voting power: Earnest Partners LLC holds sole power to vote or direct the vote of 1,805,630 shares.
  • Shared voting power: The firm reported shared voting power over 165,171 shares.
  • Sole dispositive power: Earnest Partners LLC holds sole power to dispose or direct the disposition of all 2,629,631 shares.
  • Filer classification: Earnest Partners LLC is filing as an investment adviser, organized in Delaware, with offices at 1180 Peachtree Street NE, Suite 2300, Atlanta, Georgia 30309.
  • Event date: The date of the event requiring this filing was September 30, 2026.

Earnest Partners' Amendment No. 13 Filing on Core Laboratories Ownership

Earnest Partners LLC, a Delaware-organized investment adviser, submitted Amendment No. 13 to its Schedule 13G regarding its holdings in Core Laboratories Inc. /DE/ (NYSE:CLB), whose principal executive offices are located at 6316 Windfern Road, Houston, Texas, 77040. The filing was signed by James M. Wilson, Chief Compliance Officer, and dated November 12, 2026, with a triggering event date of September 30, 2026.

According to the filing, Earnest Partners LLC beneficially owns 2,629,631 shares of Core Laboratories common stock (CUSIP 21867A105), representing 5.7% of the class. Of those shares, the firm reports sole voting power over 1,805,630 shares and shared voting power over 165,171 shares. Sole dispositive power extends to all 2,629,631 shares, while shared dispositive power is reported as zero.

The filing states that Earnest Partners LLC is filing as an investment adviser in accordance with Rule 240.13d-1(b)(1)(ii)(E), and that "no client interest relates to more than five percent of the class." The firm certified that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."

What Was Disclosed

Earnest Partners LLC disclosed an aggregate beneficial ownership of 2,629,631 shares, or 5.7%, of Core Laboratories Inc. common stock as of September 30, 2026, filing as an investment adviser with no single client holding more than 5% of the class.